Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 797,622
  • Shares Outstanding, K 13,783
  • Annual Sales, $ 105,560 K
  • Annual Income, $ 18,720 K
  • 60-Month Beta 1.04
  • Price/Sales 7.61
  • Price/Cash Flow 25.36
  • Price/Book 3.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.41
  • Number of Estimates 2
  • High Estimate 0.42
  • Low Estimate 0.39
  • Prior Year 0.53
  • Growth Rate Est. (year over year) -22.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.02 +13.42%
on 09/23/19
59.76 -3.16%
on 10/11/19
+3.55 (+6.54%)
since 09/18/19
3-Month
39.70 +45.77%
on 07/24/19
59.76 -3.16%
on 10/11/19
+16.79 (+40.87%)
since 07/18/19
52-Week
29.01 +99.48%
on 03/27/19
59.76 -3.16%
on 10/11/19
+17.06 (+41.80%)
since 10/18/18

Most Recent Stories

More News
Zacks.com featured highlights include: KB Home, Crocs, NetEase, Taylor Morrison Home and Anika Therapeutics

Zacks.com featured highlights include: KB Home, Crocs, NetEase, Taylor Morrison Home and Anika Therapeutics

NTES : 286.03 (-0.98%)
KBH : 36.48 (+0.94%)
TMHC : 27.65 (-0.11%)
ANIK : 57.87 (-0.70%)
CROX : 32.79 (+0.15%)
5 Stocks With Recent Price Strength Despite Trade Jitters

Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

NTES : 286.03 (-0.98%)
KBH : 36.48 (+0.94%)
TMHC : 27.65 (-0.11%)
ANIK : 57.87 (-0.70%)
CROX : 32.79 (+0.15%)
Anika to Showcase Joint Preservation and Restoration Portfolio at the Annual Scientific Meeting of the International Society for Hip Arthroscopy

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid ("HA") technology platform,...

ANIK : 57.87 (-0.70%)
Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its proprietary hyaluronic acid ("HA") technology platform to provide treatments...

ANIK : 57.87 (-0.70%)
Cosmetic Surgery Market Still Has Room to Grow | Emerging Players - GC Aesthetics, Sientra, Polytech Health & Aesthetics, HansBiomed

HTF MI newly added the Global Cosmetic Surgery Market Study that gives meticulous investigation of current scenario of the Market size, share, demand, growth, trends, and forecast in the coming years.The...

ANIK : 57.87 (-0.70%)
HOLX : 49.92 (+1.17%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
Anika to Issue Third-quarter 2019 Financial Results and Business Highlights on Thursday, October 24

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2019 financial results after the close of the market on Thursday, October 24, 2019 and hold its...

ANIK : 57.87 (-0.70%)
Constellation Pharmaceuticals (CNST) Looks Good: Stock Adds 8.3% in Session

Constellation Pharmaceuticals (CNST) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

ANIK : 57.87 (-0.70%)
CNST : 12.73 (+2.08%)
Anika to Showcase Joint Preservation and Restoration Portfolio at the 2019 World Congress of the International Cartilage Regeneration and Joint Preservation Society

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated regenerative therapies company leveraging its proprietary hyaluronic acid ("HA") technology platform, today announced plans to showcase its...

ANIK : 57.87 (-0.70%)
Shares of ANIK Up 68.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Anika Therapeuti (NASDAQ:ANIK) on April 29th, 2019 at $33.16. In approximately 5 months, Anika Therapeuti has returned 68.58% as of today's recent price of $55.90.

ANIK : 57.87 (-0.70%)
Axsome (AXSM) Catches Eye: Stock Jumps 9.3%

Axsome (AXSM) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

ANIK : 57.87 (-0.70%)
AXSM : 21.04 (-6.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ANIK with:

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

2nd Resistance Point 60.24
1st Resistance Point 59.06
Last Price 57.87
1st Support Level 57.22
2nd Support Level 56.56

See More

52-Week High 59.76
Last Price 57.87
Fibonacci 61.8% 48.01
Fibonacci 50% 44.38
Fibonacci 38.2% 40.76
52-Week Low 29.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar